{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:45:06Z","timestamp":1777635906557,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.yexcr.2017.12.020","type":"journal-article","created":{"date-parts":[[2017,12,23]],"date-time":"2017-12-23T18:53:02Z","timestamp":1514055182000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Collagen prolyl hydroxylase 3 has a tumor suppressive activity in human lung cancer"],"prefix":"10.1016","volume":"363","author":[{"given":"Yong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miljana","family":"Nenkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Haase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iver","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2017.12.020_bib1","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA: A Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2017.12.020_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000070306","article-title":"Identification of a novel homeobox-containing gene, LAGY, which is downregulated in lung cancer","volume":"64","author":"Chen","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.yexcr.2017.12.020_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/ijc.22753","article-title":"Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer","volume":"121","author":"Chen","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2017.12.020_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/path.4469","article-title":"HOPX is methylated and exerts tumour-suppressive function through Ras-induced senescence in human lung cancer","volume":"235","author":"Chen","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexcr.2017.12.020_bib5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bbrc.2004.03.060","article-title":"LEPREL1, a novel ER and Golgi resident member of the Leprecan family","volume":"317","author":"Jarnum","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2017.12.020_bib6","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/sj.bjc.6605042","article-title":"The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer","volume":"100","author":"Shah","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2017.12.020_bib7","series-title":"Posttranslational Modifications of Proteins","first-page":"1","article-title":"Hydroxylation of proline and lysine residues in collagens and other animal and plant proteins","author":"Kivirikko","year":"1992"},{"key":"10.1016\/j.yexcr.2017.12.020_bib8","doi-asserted-by":"crossref","first-page":"23615","DOI":"10.1074\/jbc.M312807200","article-title":"Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes","volume":"279","author":"Vranka","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2017.12.020_bib9","doi-asserted-by":"crossref","first-page":"19432","DOI":"10.1074\/jbc.M802973200","article-title":"Characterization of recombinant human prolyl 3-hydroxylase isoenzyme 2, an enzyme modifying the basement membrane collagen IV","volume":"283","author":"Tiainen","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2017.12.020_bib10","doi-asserted-by":"crossref","first-page":"e39469","DOI":"10.1371\/journal.pone.0039469","article-title":"Deregulation of Rab and Rab effector genes in bladder cancer","volume":"7","author":"Ho","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2017.12.020_bib11","doi-asserted-by":"crossref","first-page":"E1617","DOI":"10.1210\/jc.2013-3799","article-title":"Identification of targets of Twist1 transcription factor in thyroid cancer cells","volume":"99","author":"Di Maro","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yexcr.2017.12.020_bib12","doi-asserted-by":"crossref","first-page":"109759","DOI":"10.1155\/2013\/109759","article-title":"LEPREL1 expression in human hepatocellular carcinoma and its suppressor role on cell proliferation","volume":"2013","author":"Wang","year":"2013","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.yexcr.2017.12.020_bib13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/bjc.2012.380","article-title":"The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma","volume":"107","author":"Hatzimichael","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2017.12.020_bib14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00292-012-1586-8","article-title":"Evaluation of a cell block method in cytological diagnostics","volume":"33","author":"Weihmann","year":"2012","journal-title":"Der Pathol."},{"key":"10.1016\/j.yexcr.2017.12.020_bib15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bjc.2011.28","article-title":"DSC3 expression is regulated byp53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer","volume":"104","author":"Cui","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2017.12.020_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/10409231003627991","article-title":"Prolyl 4-hydroxylase","volume":"45","author":"Gorres","year":"2010","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.yexcr.2017.12.020_bib17","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/sj.onc.1203696","article-title":"Gros1, a potential growth suppressor on chromosome 1: its identity to basement membrane-associated proteoglycan, leprecan","volume":"19","author":"Kaul","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2017.12.020_bib18","series-title":"Connective Tissue and Its Heritable Disorders: Molecular, Genetic and Medical Aspects","first-page":"159","article-title":"The collagen family: structure, assembly, and organization in the extracellular matrix","author":"Kielty","year":"2003"},{"key":"10.1016\/j.yexcr.2017.12.020_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yexcr.2017.12.020_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/03008207.2013.800867","article-title":"Collagen prolyl3-hydroxylation: a major role for a minor post-translational modification?","volume":"54","author":"Hudson","year":"2013","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.yexcr.2017.12.020_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","article-title":"CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta","volume":"127","author":"Morello","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2017.12.020_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng1968","article-title":"Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta","volume":"39","author":"Cabral","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2017.12.020_bib23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ajhg.2011.08.003","article-title":"High myopia caused by a mutation in LEPREL1, encoding prolyl 3-hydroxylase 2","volume":"89","author":"Mordechai","year":"2011","journal-title":"Am. J. Human. Genet."},{"key":"10.1016\/j.yexcr.2017.12.020_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.bi.64.070195.002155","article-title":"Collagens: molecular biology, diseases, and potentials for therapy","volume":"64","author":"Prockop","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.yexcr.2017.12.020_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1006\/scdb.1999.0317","article-title":"Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones","volume":"10","author":"Lamande","year":"1999","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2017.12.020_bib26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2006.051321","article-title":"The role of type IV collagen and basement membranes in cancer progression and metastasis","volume":"168","author":"Tanjore","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2017.12.020_bib27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/carcin\/20.5.749","article-title":"Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis","volume":"20","author":"Zeng","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yexcr.2017.12.020_bib28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.928","article-title":"Loss of alveolar basement membrane type IV collagenalpha3, alpha4, and alpha5 chains in bronchioloalveolar carcinoma of the lung","volume":"194","author":"Nakano","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexcr.2017.12.020_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2407-13-154","article-title":"Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop","volume":"13","author":"Ohlund","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2017.12.020_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1471-2407-10-364","article-title":"Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion","volume":"10","author":"Jia","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2017.12.020_bib31","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1158\/0008-5472.CAN-13-1796","article-title":"The \u03b1v\u03b26 integrin promotes an osteolytic program through upregulation of MMP2","volume":"74","author":"Dutta","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2017.12.020_bib32","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.18632\/oncotarget.6815","article-title":"Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2017.12.020_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.seminoncol.2006.04.013","article-title":"Targeting loss-of-function mutations in tumor-suppressor genes as a strategy for development of cancer therapeutic agents","volume":"33","author":"Wang","year":"2006","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.yexcr.2017.12.020_bib34","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/cncr.29140","article-title":"Therapeutic targeting of tumor suppressor genes","volume":"121","author":"Morris","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.yexcr.2017.12.020_bib35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/ars.2009.2901","article-title":"Prolyl hydroxylases and therapeutics","volume":"12","author":"Smith","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.yexcr.2017.12.020_bib36","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/jcbfm.2012.28","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics?","volume":"32","author":"Karuppagounder","year":"2012","journal-title":"J. Cereb. Blood Flow. Metab.: Off. J. Int. Soc. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.yexcr.2017.12.020_bib37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1517\/13543784.2011.566861","article-title":"HIF prolyl hydroxylase inhibitors for anemia","volume":"20","author":"Muchnik","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.yexcr.2017.12.020_bib38","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3109\/08923973.2010.545418","article-title":"Prolyl hydroxylase and hypoxia inducible factor: potential targets for cancer therapy","volume":"33","author":"Prabhu","year":"2011","journal-title":"Immunopharmacol. Immunotoxicol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482717306730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482717306730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T20:46:48Z","timestamp":1654721208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482717306730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0014482717306730"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2017.12.020","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Collagen prolyl hydroxylase 3 has a tumor suppressive activity in human lung cancer","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2017.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}